Chasteberry (Vitex) for PMS and Luteal Phase via Prolactin Modulation in 2025 Trial
WELLNESS

Chasteberry (Vitex) for PMS and Luteal Phase via Prolactin Modulation in 2025 Trial

By Sophie · · Phytotherapy Research 2025
KO | EN

Chasteberry (Vitex agnus-castus) standardized extract at 4mg/day for 12 weeks significantly improved PMS symptoms in 100 patients in a 2025 trial, building on a long history of clinical evidence for this PMS standard botanical.

The Phytotherapy Research 2025 RCT enrolled 100 patients with moderate-to-severe PMS for 12 weeks of standardized chasteberry extract 4mg/day. Composite PMS score -54%, breast pain -62%, depressed mood -38%, bloating -42%, irritability -47%. Consistent with the BMJ 2001 classic RCT (178 subjects, 50%+ improvement).

What is Chasteberry

Chasteberry (Vitex agnus-castus) is a Verbenaceae perennial shrub. English: “Chasteberry, Chaste Tree, Monk’s Pepper”. Latin “agnus” (lamb) + “castus” (chaste) — medieval monks reportedly used it for libido suppression. Native to the Mediterranean and Western Asia. Small purple-white lilac-like flowers; small black peppercorn-sized fruits (medicinal).

Active compound matrix:

  • Iridoid glycosides (aucubin, agnuside): standardization marker
  • Flavonoids (casticin): dopamine activity
  • Diterpenes (rotundifuran): partial dopamine D2 receptor binding
  • Essential oil: cineole, limonene
  • Fatty acids: linoleic, oleic

2,000+ year tradition: Greek Hippocrates as a uterine herb, medieval monasteries. 1990s German clinical accumulation. Now listed by ESCOP, EMA, and German Commission E for PMS.

Multi-Target Mechanisms

1. Partial Dopamine D2 Receptor Binding → Prolactin Reduction:

  • Diterpenes partially activate pituitary D2 receptors
  • Reduce prolactin release → support luteal phase defect
  • Decrease PMS breast pain and dysmenorrhea
  • Mild hyperprolactinemia support

2. Luteal Phase Balance → Fertility Preparation:

  • Luteal phase defect is a subtle infertility cause
  • Supports progesterone secretion
  • Natural fertility support (does not contain hormones)

3. PMS Multi-Symptom:

  • Breast pain, bloating, irritability, depression, headache
  • Pathway through dopamine/prolactin rather than direct hormone

4. Mild Androgen Modulation:

  • Some PCOS support (in insulin + prolactin matrix)

Clinical Data

  • BMJ 2001 RCT 178 subjects: 50%+ PMS improvement (classic)
  • Phytotherapy Research 2025 RCT 100 subjects 12 weeks: PMS -54%, breast pain -62%
  • Meta-analysis 2023 (17 RCTs): consistent PMS effects
  • Clinical 2018: luteal phase defect + fertility preparation
  • ESCOP, EMA, German Commission E listed

Market Context

Supplements:

  • Standardized extract (agnuside 0.6%) 4mg/day
  • General extract capsules 175~225mg/day
  • 60 tabs $25~60
  • PMS matrix combinations (chasteberry + magnesium + B6)
  • Minimal dietary use (strong flavor, occasional pepper substitute)

Cautions

  • Pregnancy: avoid after pregnancy onset (prolactin reduction can interfere with lactation). Use before conception for luteal phase support
  • Lactation: avoid (prolactin reduction → reduced milk)
  • Hormonal medications (contraceptives, HRT): subtle effect, clinical evaluation
  • Dopamine medications (Parkinson’s, psychiatric): clinical evaluation
  • Estrogen-sensitive cancers: generally safe (no direct estrogen activity), clinical evaluation
  • Re-evaluate at 12~16 weeks: try alternatives if no response

Synergy Matrix

  • Magnesium + vitamin B6: classic PMS matrix
  • Inositol (L21) + chasteberry: PCOS luteal matrix
  • Evening primrose oil (GLA): breast pain synergy
  • Black cohosh (L23): perimenopausal matrix (different target)

Consumer Message

Hormonal contraceptives and SSRIs are first-line for PMS but bring side effects and conflict with pregnancy planning. Chasteberry offers a meaningful natural option. Avoid in pregnancy and lactation, evaluate at 12~16 weeks. Also supports luteal phase defect + fertility preparation. Combine with magnesium, B6, and evening primrose. A spring matrix option for women in their reproductive years.